Speed Post News Network

New Delhi : The National Pharmaceutical Pricing Authority (NPPA) notified the ceiling price of orthopaedic knee implants on  August 16, 2017, by invoking extraordinary powers, in public interest, under Para 19 of Drugs Prices Control Order (DPCO) 2013, for a period of one year. Subsequently, vide notification dated August 13, 2018, the applicability of ceiling prices fixed for orthopaedic knee implants was extended for another one year,  up to August 15, 2019. Accordingly, the cost of knee implants was reduced significantly, up to 69%, resulting in a notional saving of Rs 1,500 crore per annum to the consumers.

The NPPA, in its meeting held on August 8,  2019, reviewed the matter. It was noted that there has been an increased access due to knee implants becoming affordable. As per the data submitted by manufacturers and importers, an increase of 30% in the sales of knee implants has been reported during the period of July, 2018 to June, 2019.

The knee implant is a non-scheduled medical device / drug for which DPCO, 2013, allows an annual increase up to 10% of MRP. However, this was not permitted in 2018.

Though the industry has requested for a 20% (10% for the year 2018 and 10% for the year 2019) increase in the price of knee implants, it was decided to further monitor the price increase of knee implants as per para 20 of the DPCO, 2013, that restricts price increase beyond 10% in a given year. This shall be subject to a review after one year, according to a PIB release.

Leave a Reply

Your email address will not be published. Required fields are marked *